[1]
Kaplan, M. et al. 2021. Efficacy and safety of single high-dose versus double high-dose intracoronary bolus tirofiban in patients with ST-segment elevation myocardial infarction. The European Research Journal. 7, 1 (Jan. 2021), 12–21. DOI:https://doi.org/10.18621/eurj.560531.